publication date: May. 2, 2014


CL40-18c.html

CFO Dwain Morris Leaves MD Anderson

DWAIN MORRIS is leaving his job as vice president and chief financial officer of MD Anderson Cancer Center to become the chief financial officer for DiabetesAmerica, a multisite provider of comprehensive diabetes care.

Morris will provide financial and operational leadership for DiabetesAmerica’s locations in Texas. His last day at MD Anderson will be June 6.

In a note to faculty and staff, Leon Leach, MD Anderson’s executive vice president and chief business officer, wrote:

“Dwain joined MD Anderson as director for enterprise reporting in 1999 and became chief financial officer in 2008. During his tenure, the institution grew exponentially, from total operating revenues of $930 million in Fiscal Year 1999 to nearly $4 billion in FY13.

He guided MD Anderson through our first external financial audit, and established a practice of annual external financial audits that set a gold standard for other UT System institutions and served as a model of responsible financial stewardship across all Texas state agencies.

He put into practice transparent methods of sharing financial information because of his belief in the importance of two-way communication and in educating all employees on how external and internal factors come together to impact us.

Dwain has built a strong team of professionals who are extremely knowledgeable and dedicated and will ensure the operational and strategic financial activities continue to move forward. These folks will report directly to me while we conduct a search to fill the CFO position.

Dwain has been an integral member of the institution’s executive team. His leadership and expertise has helped MD … Continue reading 40-18 In Brief / Funding Opportunity

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.